IS2649B - 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders - Google Patents
1,2,4-triaminobenzene derivatives useful for treating central nervous system disordersInfo
- Publication number
- IS2649B IS2649B IS7856A IS7856A IS2649B IS 2649 B IS2649 B IS 2649B IS 7856 A IS7856 A IS 7856A IS 7856 A IS7856 A IS 7856A IS 2649 B IS2649 B IS 2649B
- Authority
- IS
- Iceland
- Prior art keywords
- nervous system
- central nervous
- system disorders
- derivatives useful
- treating central
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200202012 | 2002-12-27 | ||
PCT/DK2003/000906 WO2004058739A1 (en) | 2002-12-27 | 2003-12-18 | 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system |
Publications (2)
Publication Number | Publication Date |
---|---|
IS7856A IS7856A (en) | 2005-05-23 |
IS2649B true IS2649B (en) | 2010-08-15 |
Family
ID=35295526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7856A IS2649B (en) | 2002-12-27 | 2005-05-23 | 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders |
Country Status (17)
Country | Link |
---|---|
KR (1) | KR20050089862A (en) |
CN (1) | CN100448867C (en) |
AR (1) | AR042656A1 (en) |
BR (1) | BR0317748A (en) |
CL (1) | CL2003002748A1 (en) |
EA (1) | EA008589B1 (en) |
HK (1) | HK1088317A1 (en) |
IS (1) | IS2649B (en) |
MY (1) | MY139844A (en) |
NO (1) | NO20053612L (en) |
PE (1) | PE20041015A1 (en) |
PL (1) | PL377221A1 (en) |
SI (1) | SI1578740T1 (en) |
TW (1) | TWI325414B (en) |
UA (1) | UA79666C2 (en) |
UY (1) | UY28151A1 (en) |
ZA (1) | ZA200504565B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4200259A1 (en) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
DE19539861A1 (en) * | 1995-10-26 | 1997-04-30 | Asta Medica Ag | Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases |
GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
US6117900A (en) * | 1999-09-27 | 2000-09-12 | Asta Medica Aktiengesellschaft | Use of retigabine for the treatment of neuropathic pain |
US6589986B2 (en) * | 2000-12-20 | 2003-07-08 | Wyeth | Methods of treating anxiety disorders |
-
2003
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/en not_active Expired - Fee Related
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/en not_active Application Discontinuation
- 2003-12-18 UA UAA200507206A patent/UA79666C2/en unknown
- 2003-12-18 PL PL377221A patent/PL377221A1/en unknown
- 2003-12-18 EA EA200501053A patent/EA008589B1/en not_active IP Right Cessation
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/en not_active IP Right Cessation
- 2003-12-18 TW TW092135930A patent/TWI325414B/en not_active IP Right Cessation
- 2003-12-18 SI SI200330827T patent/SI1578740T1/en unknown
- 2003-12-22 AR ARP030104782A patent/AR042656A1/en unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/en not_active Application Discontinuation
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/en unknown
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
-
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/en not_active Application Discontinuation
-
2005
- 2005-05-23 IS IS7856A patent/IS2649B/en unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/en unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/en not_active Application Discontinuation
-
2006
- 2006-08-04 HK HK06108672.2A patent/HK1088317A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AR042656A1 (en) | 2005-06-29 |
EA008589B1 (en) | 2007-06-29 |
MY139844A (en) | 2009-11-30 |
ZA200504565B (en) | 2006-08-30 |
PL377221A1 (en) | 2006-01-23 |
UY28151A1 (en) | 2004-07-30 |
NO20053612L (en) | 2005-09-23 |
HK1088317A1 (en) | 2006-11-03 |
CN100448867C (en) | 2009-01-07 |
NO20053612D0 (en) | 2005-07-25 |
TW200413280A (en) | 2004-08-01 |
CL2003002748A1 (en) | 2005-04-08 |
CN1732162A (en) | 2006-02-08 |
PE20041015A1 (en) | 2005-01-08 |
SI1578740T1 (en) | 2007-08-31 |
TWI325414B (en) | 2010-06-01 |
UA79666C2 (en) | 2007-07-10 |
BR0317748A (en) | 2005-11-22 |
EA200501053A1 (en) | 2005-12-29 |
KR20050089862A (en) | 2005-09-08 |
IS7856A (en) | 2005-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2019521I1 (en) | Rapamycin derivative for the treatment of solid tumors associated with unregulated angiogenesis | |
EE200100441A (en) | Monoamine reuptake inhibitors for the treatment of central nervous system disorders | |
DK1474416T3 (en) | Dihydrobenzodiazepine-2-one derivatives for the treatment of neurological disorders | |
DK1144388T3 (en) | Acyl derivatives that treat VLA-4-related disorders | |
EP1434801A4 (en) | Treatment for central nervous system disorders | |
AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
DE60216115D1 (en) | BENZIMIDAZO 4,5-föISOCHINOLINONE DERIVATIVES | |
IS7941A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
EP1545700A4 (en) | Methods for treating central nervous system damage | |
ID30276A (en) | METHODS FOR TREATING SEXUAL DISORDERS | |
DE60214428D1 (en) | 1, 4-DIHYDRO-1, 4-DIPHENYLPYRIDINE DERIVATIVES | |
IL176581A0 (en) | Immunomodulatory compounds for the treatment of central nervous system disorders | |
NO20034930D0 (en) | Substituted cyclohexane-1,4-diamine derivatives | |
AP2210A (en) | 4-tetrazolyl-4phenylpiperidine derivatives for treating pain. | |
DK1339406T3 (en) | Piperazine derivatives, processes for their preparation and use thereof for the treatment of central nervous system disorders | |
NO20033821D0 (en) | Use of GABA A inverse agonists in combination with nicotine receptor delagonists, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders | |
DK1578740T3 (en) | 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders | |
ATE452892T1 (en) | SUBSTITUTED 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDO-(1,2A) PYRIMIDIN-4-ONE DERIVATIVES | |
NO20041386L (en) | Combinations for the treatment of immuno-inflammatory disorders | |
DE69923189D1 (en) | Device for tensioning risers | |
AU2003250475A8 (en) | 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors | |
IL170710A0 (en) | Selective cytokine inhibitory drugs for treating disorders of the central nervous system | |
HK1080859A1 (en) | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders | |
MXPA03006607A (en) | Combined method for treating hormono-dependent disorders. | |
PT1294710E (en) | UTILARY DERIVATIVES FOR THE TREATMENT OF DISORDERS OF THE CNS |